about
Evaluation of aminohydantoins as a novel class of antimalarial agents.Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen.Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agentsCostimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruziPolyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infectionAn immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescenceDipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.Absence of calcium-independent phospholipase A2 β impairs platelet-activating factor production and inflammatory cell recruitment in Trypanosoma cruzi-infected endothelial cells.Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.Investigations of TB vaccine-induced mucosal protection in mice.Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.Synthesis, antimalarial properties and 2D-QSAR studies of novel triazole-quinine conjugates.Automated generation of immature dendritic cells in a single-use system.Thermal and nutritional regulation of ribosome hibernation in
P50
Q33636531-AD55719B-4ABE-4FAA-B188-CAA2AEA6C38AQ33675887-4E9E0609-6C53-4DAD-81AE-76C9BE5BC5BBQ34003026-1BA14590-E373-4443-B6AF-7F50C8C00749Q34550753-C0BE7BB8-F048-4E72-AAE5-36B31E67ACFCQ35071882-D6269945-2E3F-437E-829C-A7B947802971Q35073839-A64618BF-A070-4FC7-ABC9-D7FE7AF1DF86Q35815577-2943E14D-4949-45F4-810B-701562AC47E4Q35997688-ED895647-3E07-4100-94E5-2E8828C9AC73Q36136972-9FFE6CF8-735C-496D-88B7-1A6F23EBA847Q36151179-D6C8E313-7E08-482E-B4E0-3D8E24C0C694Q36163097-99004C19-AE8D-43E8-8A7E-168F09F92187Q36256258-B6B9B1C8-4F77-483E-ABDD-83C23BB2F3BFQ36625669-C131CBD3-ABBB-49BE-8DBC-0673203E48CEQ36911412-459C9A2F-7413-4CA0-9C24-F55397022665Q36970825-45DAF28A-281A-4B55-B7F9-F4DE02092787Q37668444-74BDA9AA-8365-4E11-BC32-72C99BF4B9A0Q40157048-0175C8B3-81C5-47A7-86CC-21C13974D139Q42417060-C3E0C063-C2C2-441B-9B5E-8705C4BF9DC3Q42957081-0F7EB2BC-2F43-42B6-8F4E-487A60E7E19FQ44149326-1FFE8C82-E5CC-4EEC-BF36-C15E409F75C1Q53760447-9A9F9180-C832-40BD-ABD3-E957DE370534Q54240461-8A072AAA-F0B5-4842-B6FC-F5590CCD0E4CQ57294643-D55042B0-7CC0-4E36-81AE-9789E0734749
P50
description
researcher
@en
wetenschapper
@nl
name
C S Eickhoff
@en
C S Eickhoff
@nl
type
label
C S Eickhoff
@en
C S Eickhoff
@nl
prefLabel
C S Eickhoff
@en
C S Eickhoff
@nl
P108
P106
P31
P496
0000-0002-5161-3603